MoisturePlus Contact Solution Recall
Attorney
(866) 735-1102 Ext 335
Posted by
Steve LombardiMay 30, 2007 9:00 AMDo you wear eye contacts? Are you suffering from pain in the eye or a mild irritation? Have you been using MoisturePlus contact solution? Are you aware there is a voluntary recall underway by the company that sells this product?
Know your rights, monitor your health and seek legal advice early from a qualified lawyer. The insurance industry spends billions of dollars to convince the average citizen that lawyers are the enemy. But in reality there are only two reasons an insurance company sends a representative to talk with you. One, to figure out a way to deny paying your claim; or two, to get you to prejudice your claim so they have to pay less. In the end it is only the lawyer that is on the side of those whose backs this country is built.
Do you wear eye contacts? Are you suffering from pain in the eye or a mild irritation? Have you been using MoisturePlus contact solution? Are you aware there is a voluntary recall underway by the company that sells this product?
Acanthamoeba keratitis is a bacterial eye infection caused by using an impure solution. It can result in permanent visual impairment or blindness. The CDC reported an increased incidence of this condition with use of contact solutions. That was followed by a voluntary recall of MoisturePlus contact solution.
The FDA reports, "[c]ontact lens wearers should consult with their eye doctor if they have any of the following symptoms: eye pain, eye redness, blurred vision, sensitivity to light, sensation of something in the eye, and excessive tearing. The symptoms, which can last several weeks to months, are not the same for everybody. Early in the infection, the symptoms of AK can be very similar to the symptoms of other more common eye infections but AK may eventually cause severe pain and possible vision loss with some patients requiring a corneal transplant if untreated."
The Handbook of Ocular Disease Management provides, "Signs and Symptoms: Acanthamoeba keratitis can occur in patients of any age, sex or race, but mostly manifests in young, healthy adults. The list of risk factors is long: corneal foreign body, contact with non-sterile water, bullous keratopathy, neurotrophic keratopathy, herpes simplex keratitis, radial keratotomy, swimming and scuba diving, basement membrane dystrophy, contact lens wear and bacterial keratitis. Cases sometimes arise with no identifiable risk factors. Essentially, any event that disrupts the corneal epithelium is a potential risk factor for Acanthamoeba keratitis.
Patients with Acanthamoeba keratitis typically present with a unilateral, red, painful eye. Initially, there is typically a non-specific epitheliopathy which can progress to ulceration with infiltration. Limbititis occurs as the initial finding in 94% of early stage cases and in 84% of late-stage cases.1-3 Another common finding is radial keratoneuritis, or perineuritis; this involves irregularly thickened corneal nerves in the anterior to mid-stroma with shaggy borders. Other clinical signs of Acanthamoeba keratitis include irregular epithelial defect, corneal microcysts, punctate keratopathy, bullous keratopathy, disciform stromal keratitis, pseudodendritic keratitis, anterior uveitis and a granulomatous stromal reaction. While Acanthamoeba keratitis has historically been associated with stromal ring infiltrate formation, only 6% of early cases and 16% of late cases actually present in this manner clinically.1-3
About half of patients report significant pain, the rest experience only mild irritation and foreign-body sensation.4,5 Those who do report pain often present a degree much worse than the clinical appearance suggests. Rarely is Acanthamoeba keratitis correctly diagnosed in the early stage. It typically follows a chronic course that waxes and wanes over weeks to months and never fully heals despite seemingly appropriate therapy. In fact, the diagnosis is often finally made when all other treatments fail."
http://www.revoptom.com/handbook/oct02_sec3_2.htm